In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...

In this final video of a three-part video series, Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and a ...

Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The next step for the Rise For Health study researchers is to study the health benefits of frequent standing in older men and ...

Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure ...

The biosimilar will be available to any licensed specialty pharmacy in the United States at a 95% discount from Stelara, starting January 1, 2026.

Large language models (LLMs) were more likely to suggest inferior treatment options when reviewing hypothetical cases when ...

National registry study finds overall survival improved across the board after the introduction of immune checkpoint ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

New research highlights the potential risks of skipping nasogastric tubes after esophageal surgery, suggesting they may reduce anastomotic leak rates. Skipping the use of a nasogastric (NG) tube after ...

COVID-19 vaccine proves cost-effective, especially for older adults, significantly reducing illness and hospitalizations across all age groups.